Macter expands Cobolmin range with sublingual option

MG News | December 22, 2025 at 03:55 PM GMT+05:00

0:00

December 22, 2025 (MLN): Macter International Limited (PSX: MACTER) introduced Cobolmin SL, a sublingual formulation of Mecobalamin.

The company stated that Cobolmin SL offers rapid absorption and enhanced convenience for patients through sublingual administration, the company’s filing on PSX revealed today.

The product expands the existing Cobolmin range, which includes tablets and injections, and underscores Macter International’s focus on innovation in healthcare.

At the time of writing, MACTER shares were trading at Rs 337.59, up 2.51 points, or 0.75%.

Copyright Mettis Link News

Related News

PSX finds its stocking power, investor base tops 500K

PSX Closing Bell: Bulls in the Driver’s Seat

Stylers International H1 profit rises 8%

Name	Price/Vol	%Chg/NChg
KSE100	168,893.09 355.32M	2.59% 4266.79
ALLSHR	100,888.78 687.85M	1.91% 1889.56
KSE30	51,723.30 154.72M	2.74% 1380.77
KMI30	236,793.15 125.14M	3.40% 7778.72
KMIALLSHR	64,642.45 317.23M	2.51% 1584.54
BKTi	49,503.80 58.63M	0.97% 475.26
OGTi	32,753.55 16.04M	2.00% 643.61

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	66,185.00	67,760.00 64,325.00	-1640.00 -2.42%
BRENT CRUDE	71.88	71.96 70.69	0.12 0.17%
RICHARDS BAY COAL MONTHLY	96.00	0.00 0.00	-3.50 -3.52%
ROTTERDAM COAL MONTHLY	107.95	107.95 107.95	0.30 0.28%
USD RBD PALM OLEIN	1,071.50	1,071.50 1,071.50	0.00 0.00%
CRUDE OIL - WTI	66.60	66.67 65.38	0.12 0.18%
SUGAR #11 WORLD	14.05	14.10 13.78	0.18 1.30%